This week’s Spotlight interview shines on Daphne Slaughter, the Neurology Department’s newest grants and contracts manager.
A novel application of zoledronic acid, a bisphosphonate typically prescribed to prevent or treat osteoporosis, is being assessed in a large-scale trial for its potential to prevent fractures in se
Meet Greg Monroe! Greg is living well with Young Onset Parkinson’s Disease (YOPD) and receives care at the Duke Movement Disorders Center. Tell us a little about yourself.
Members of the Duke Neurology Department advanced the fields of clinical, translational, and basic neuroscience this April with 14 new peer-reviewed studies.
Daniel Gingerich joined the laboratory of Ornit Chiba-Falek, PhD, last year, exactly two days before the COVID-19 pandemic forced a campus-wide shut down, forcing him to learn a new set of tech
An unfortunate biological “feed-forward” loop drives cartilage cells in an arthritic joint to actually contribute to progression of the disease, say researchers at Duke University and Washington Un
A recent study led by Duke vascular neurologist Brian Mac Grory, MB, BCh, BAO, examined treatment for central retinal artery occlusion (CRAO or “eye stroke”)—a rare type of stroke characterized by
The American Academy of Neurology (AAN) has moved its annual meeting to a virtual setting this year, but its offerings of the latest education and scientific programming continue.